OctoPlus N.V.
OctoPlus N.V., headquartered in the Netherlands, is a prominent player in the biopharmaceutical industry, specialising in the development of innovative drug delivery systems. Founded in 2000, the company has achieved significant milestones, including advancements in its proprietary technology platforms that enhance the efficacy and safety of therapeutic agents.
With a focus on injectable formulations, OctoPlus offers unique services that cater to the specific needs of pharmaceutical companies, including formulation development and clinical trial support. Their expertise in complex drug delivery systems positions them as a trusted partner in the industry.
Recognised for their commitment to quality and innovation, OctoPlus N.V. continues to strengthen its market position, contributing to the advancement of healthcare solutions globally.
+54 vs industry average
OctoPlus N.V.’s score of 92 is higher than 95% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at OctoPlus N.V.?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has reduced its overall emissions by 19% since 0
Reported emissions
No reported emissions data is available for OctoPlus N.V. yet.
OctoPlus N.V.'s reported carbon emissions
OctoPlus N.V., headquartered in the Netherlands (NL), currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of Dr. Reddy's Laboratories Limited, which influences its climate commitments and initiatives.
As part of its corporate family relationship, OctoPlus N.V. inherits climate-related targets and performance metrics from Dr. Reddy's Laboratories Limited. This includes commitments to the Science Based Targets initiative (SBTi) and participation in the Carbon Disclosure Project (CDP), both of which are cascaded down from the parent company. However, specific reduction targets or achievements for OctoPlus N.V. have not been detailed.
In the context of industry standards, OctoPlus N.V. aligns with broader climate initiatives through its association with Dr. Reddy's Laboratories Limited, which is actively engaged in reducing its carbon footprint and enhancing sustainability practices. The absence of direct emissions data suggests a need for further transparency and reporting in line with global climate commitments.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
OctoPlus N.V.’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for OctoPlus N.V. yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives
Science Based Targets Initiative
Inherited from Dr. Reddy's Laboratories Limited
Carbon Disclosure Project
Inherited from Dr. Reddy's Laboratories Limited
The Climate Pledge
UN Global Compact Climate Champions initiative
Inherited from Dr. Reddy's Laboratories Limited
RE 100
Climate Action 100
Emissions comparison with industry peers
View similar organisations
OctoPlus N.V.
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project